Clinical Trial Update: Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients

View source ↗

Summary

Astellas Pharma Korea conducted a non-interventional study to establish consensus on how to manage metastatic hormone-sensitive prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Astellas Pharma Korea, Inc. | Conditions: Metastatic Hormone-Sensitive Prostate Cancer | Status: COMPLETED